Search All News
NYPL Spanish Videos
The advancement of gene editing technology "opens up a whole another world of questions we will increasingly face," Dr. Robert Klitzman said.
Dr. Joshua Kantrowitz discusses a recent trial of CVN058, a drug that may reduce cognitive impairments in individuals with schizophrenia.
"This is a challenging time for the entire nation for many reasons: chief among them is uncertainty," says Dr. Ravi Shah.
- September 10, 2019
Dr. Katherine Elkington, Associate Professor of Clinical Psychology (in Psychiatry) at Columbia University, discusses the complex connection between suicide and substance use in adolescents.
- September 4, 2019
Dr. Blake Zakarin discusses the relationship between sleep, mental health, and suicide in adolescents and steps we can all take to improve the quality of our sleep.
- August 28, 2019
Dr. Gary Brucato, the Center of Prevention and Evaluation's Assistant Director, breaks down some of the early warning signs and symptoms of possible emergent psychotic illness.
- February 8, 2019
The Columbia Ketamine program offers innovative and responsible care for treatment-resistant depression.
Source:MedscapeOctober 30, 2017
Ecstasy "needs to be looked at in a very careful and rigorously controlled way to accrue evidence showing what it can do and what its potential liability is," says Dr. Jeffrey Lieberman.